CompletedNot Applicable

Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures

United States743 participantsStarted 2013-08

Plain-language summary

Would rapid identification of bacteria and rapid detection of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE) (using an FDA-cleared assay) in positive blood culture bottles improve patient care at Mayo Clinic Rochester (or just lead to increased cost)?

Who can participate

Age range99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Positive blood culture during the study period. * No positive blood cultures in prior 7 days * Minnesota state research authorization provided Exclusion criteria: * No Minnesota state research authorization * Deceased or transitioned to comfort care within 24 hours of enrollment * Positive blood culture in prior 7 days * Previously enrolled in this study * Negative Gram stain

What they're measuring

Duration of Antimicrobial Therapy (Hours)

Timeframe: Approximately 4 days after enrollment

Trial details

NCT IDNCT01898208

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-08

Results submitted2015-12-02

View on ClinicalTrials.gov More Bacteremia trials